Paper Details

  1. Home
  2. Paper Details

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Author: GlaabThomas, KardosPeter, VogelmeierClaus, WenckerMarion

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

The study assessed the impact of combination therapy with salmeterol/fluticasone propionate compared with salmeterol alone on moderate and severe exacerbations in patients with severe COPD and a history of repeated exacerbations. The results showed that combination therapy significantly reduced the frequency of moderate/severe exacerbations, improved health-related quality of life, peak expiratory flow, and use of rescue medication, and was well tolerated.
Paper Details　
Original Abstract of the Article :
RATIONALE: Exacerbations of chronic obstructive pulmonary disease (COPD) greatly contribute to declining health status and the progression of the disease, thereby incurring significant direct and indirect health care costs. The prevention of exacerbations, therefore, is an important treatment goal. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1164/rccm.200602-244OC

データ提供：米国国立医学図書館（NLM）

Combating COPD Exacerbations: Salmeterol/Fluticasone Propionate vs. Salmeterol

Navigating the vast expanse of chronic obstructive pulmonary disease (COPD) research, we come across a crucial quest: minimizing exacerbations. These unwelcome flare-ups can significantly impact a patient's quality of life and lead to disease progression. The authors of this study embarked on a journey to compare the effects of a combination therapy, salmeterol/fluticasone propionate, with salmeterol alone, both in patients with severe COPD who have experienced repeated exacerbations.

Combination Therapy Shows Promise in Reducing Exacerbations

The results of this study point to the potential of combination therapy. Patients receiving salmeterol/fluticasone propionate experienced a significantly lower frequency of moderate and severe exacerbations compared to those on salmeterol alone. The reduction was a remarkable 35%, suggesting a substantial benefit for patients with severe COPD.

A Breath of Fresh Air for COPD Management

The findings of this study provide hope for individuals struggling with COPD. The combination therapy demonstrates a significant reduction in exacerbations, potentially improving quality of life and slowing disease progression. As with any treatment, it's vital to consult with your doctor to determine the best course of action for your specific needs.

Dr. Camel's Conclusion

Imagine navigating a sandstorm, a challenging experience for any camel. This study shows that combining salmeterol/fluticasone propionate could be like providing a protective shield against the harsh elements of COPD exacerbations. It's a step towards a more stable and comfortable journey for those living with this chronic condition.

Date :
  1. Date Completed 2007-03-12
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

17053207

DOI: Digital Object Identifier

10.1164/rccm.200602-244OC

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.